HYLORIS PHARMACEUTIC

HYL
Real-time Quote. Real-time  - 05/26 11:35:07 am
14.94EUR -0.27%

Hyloris Pharmaceuticals Kicks Off Mid-Stage Trial of Vulvovaginal Candidiasis Treatment

11/02/2021 | 01:18am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover